These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37358553)

  • 1. Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.
    Björnson E; Adiels M; Taskinen MR; Burgess S; Rawshani A; Borén J; Packard CJ
    Eur Heart J; 2023 Oct; 44(39):4186-4195. PubMed ID: 37358553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein Characteristics and Incident Coronary Heart Disease: Prospective Cohort of Nearly 90 000 Individuals in UK Biobank.
    Jin D; Trichia E; Islam N; Bešević J; Lewington S; Lacey B
    J Am Heart Assoc; 2023 Oct; 12(20):e029552. PubMed ID: 37815053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteins.
    Björnson E; Adiels M; Bergström G; Gummesson A
    Atherosclerosis; 2024 Jan; 388():117397. PubMed ID: 38102060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis.
    Björnson E; Adiels M; Taskinen MR; Burgess S; Chapman MJ; Packard CJ; Borén J
    J Am Coll Cardiol; 2024 Jan; 83(3):385-395. PubMed ID: 38233012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study.
    Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1144-1155. PubMed ID: 38511326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Causal Roles of Circulating Remnant Lipid Profile on Cardiovascular and Cerebrovascular Diseases: Mendelian Randomization Study.
    Si S; Hou L; Chen X; Li W; Liu X; Liu C; Li Y; Yuan T; Li J; Wang B; Li H; Xue F
    J Epidemiol; 2022 May; 32(5):205-214. PubMed ID: 33441507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F; Hellénius ML; Hamsten A
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease.
    Peloso GM; Nomura A; Khera AV; Chaffin M; Won HH; Ardissino D; Danesh J; Schunkert H; Wilson JG; Samani N; Erdmann J; McPherson R; Watkins H; Saleheen D; McCarthy S; Teslovich TM; Leader JB; Lester Kirchner H; Marrugat J; Nohara A; Kawashiri MA; Tada H; Dewey FE; Carey DJ; Baras A; Kathiresan S
    Circ Genom Precis Med; 2019 May; 12(5):e002376. PubMed ID: 30939045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia.
    Wang J; Kockx M; Bolek M; Lambert T; Sullivan D; Chow V; Kritharides L
    J Lipid Res; 2024 Jul; 65(7):100577. PubMed ID: 38879166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.
    Dane-Stewart CA; Watts GF; Mamo JC; Dimmitt SB; Barrett PH; Redgrave TG
    Eur J Clin Invest; 2001 Feb; 31(2):113-7. PubMed ID: 11168448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults.
    Haslam DE; Chasman DI; Peloso GM; Herman MA; Dupuis J; Lichtenstein AH; Smith CE; Ridker PM; Jacques PF; Mora S; McKeown NM
    J Nutr; 2022 Nov; 152(11):2534-2545. PubMed ID: 36774119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.